3.1100
+0.0300
+(0.97%)
At close: January 13 at 4:00:01 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 40,000 | 1 |
| Sales | 25,044 | 2 |
| Net Shares Purchased (Sold) | 14,956 | 3 |
| Total Insider Shares Held | 4.57M | -- |
| % Net Shares Purchased (Sold) | 0.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BRATTON DOUGLAS K Beneficial Owner of more than 10% of a Class of Security | Stock Gift at price 0.00 per share. | Indirect | 0 | Dec 2, 2024 |
| JUNG CASSIE Chief Operating Officer | Sale at price 4.87 per share. | Indirect | 214 | Nov 26, 2024 |
| KORCZYNSKI SHERRY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 7, 2024 |
| WARGACKI STEPHEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 10, 2024 |
| SCHOBEL ALEXANDER MARK Officer | Sale at price 6.00 per share. | Direct | 300,000 | Mar 15, 2024 |
| SCHOBEL ALEXANDER MARK Chief Technology Officer | Sale at price 5.19 per share. | Direct | 129,685 | Mar 8, 2024 |
| SCHOBEL ALEXANDER MARK Officer | Sale at price 5.19 per share. | Direct | 129,685 | Mar 8, 2024 |
| TOTH A ERNEST JR Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| SCHOBEL ALEXANDER MARK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| BARBER DANIEL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| BOYD PETER E Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| BRAENDER LORI J General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| KRAUS CARL N Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| JUNG CASSIE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| WARGACKI STEPHEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 7, 2024 |
| KRAUS CARL N Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 9, 2023 |
| TOTH A ERNEST JR Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
| MARSHALL KEN W Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
| SCHOBEL ALEXANDER MARK Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
| BARBER DANIEL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
| BOYD PETER E Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
| BRAENDER LORI J General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
| JUNG CASSIE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
| WARGACKI STEPHEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 9, 2023 |
| BOYD PETER E Officer | Purchase at price 0.81 per share. | Direct | 4,050 | Jun 14, 2022 |
| SCHOBEL ALEXANDER MARK Chief Technology Officer | Purchase at price 0.96 per share. | Direct | 44,036 | Jun 8, 2022 |
| BARBER DANIEL Chief Executive Officer | Purchase at price 0.96 per share. | Direct | 88,073 | Jun 8, 2022 |
| BOYD PETER E Officer | Purchase at price 0.96 per share. | Direct | 2,201 | Jun 8, 2022 |
| BRAENDER LORI J General Counsel | Purchase at price 0.96 per share. | Direct | 13,211 | Jun 8, 2022 |
| KENDALL KEITH J. Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Aug 26, 2021 |
| COCHRAN JOHN Director | Stock Gift at price 0.00 per share. | Direct | 0 | May 10, 2021 |
| BRATTON DOUGLAS K Beneficial Owner of more than 10% of a Class of Security | Stock Gift at price 0.00 per share. | Direct | 0 | Mar 9, 2021 |
| SCHOBEL ALEXANDER MARK Chief Technology Officer | Sale at price 6.75 per share. | Direct | 236,250 | Feb 10, 2021 |
| SCHOBEL ALEXANDER MARK Chief Technology Officer | Sale at price 6.50 per share. | Direct | 265,148 | Feb 8, 2021 |
| KENDALL KEITH J. Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 30, 2020 |
| MAXWELL JOHN T. Chief Financial Officer | Sale at price 8.00 per share. | Direct | 24,000 | Aug 18, 2020 |
| SCHOBEL ALEXANDER MARK Chief Technology Officer | -- | Direct | -- | Jun 30, 2020 |
| KENDALL KEITH J. Chief Executive Officer | -- | Direct | -- | Jun 30, 2020 |
| KENDALL KEITH J. Chief Executive Officer | Sale at price 5.11 per share. | Direct | 255,310 | Jun 4, 2020 |
| SCHOBEL ALEXANDER MARK Chief Technology Officer | -- | Direct | -- | May 29, 2020 |
| KENDALL KEITH J. Chief Executive Officer | -- | Direct | -- | May 29, 2020 |
| SCHOBEL ALEXANDER MARK Chief Technology Officer | Sale at price 5.00 per share. | Direct | 200,000 | May 8, 2020 |
| SCHOBEL ALEXANDER MARK Chief Technology Officer | Sale at price 4.50 per share. | Direct | 180,000 | Apr 29, 2020 |
| SCHOBEL ALEXANDER MARK Chief Technology Officer | Sale at price 3.70 - 4.00 per share. | Direct | 308,000 | Apr 27, 2020 |
| SCHOBEL ALEXANDER MARK Chief Technology Officer | -- | Direct | -- | Mar 31, 2020 |
| KENDALL KEITH J. Chief Executive Officer | -- | Direct | -- | Mar 31, 2020 |
| BOYD PETER E Officer | Purchase at price 1.50 per share. | Direct | 3,000 | Mar 16, 2020 |
| BRAENDER LORI J General Counsel | Purchase at price 1.54 per share. | Direct | 21,624 | Mar 16, 2020 |
| SCHOBEL ALEXANDER MARK Chief Technology Officer | -- | Direct | -- | Feb 28, 2020 |
| KENDALL KEITH J. Chief Executive Officer | -- | Direct | -- | Feb 28, 2020 |
Related Tickers
AKBA Akebia Therapeutics, Inc.
1.8700
+6.86%
AVDL Avadel Pharmaceuticals plc
7.82
-1.01%
ESPR Esperion Therapeutics, Inc.
2.2800
-2.56%
RMTI Rockwell Medical, Inc.
2.0100
-3.37%
ETON Eton Pharmaceuticals, Inc.
14.00
+4.17%
ASRT Assertio Holdings, Inc.
0.8069
-3.53%
EBS Emergent BioSolutions Inc.
9.41
-4.76%
ITCI Intra-Cellular Therapies, Inc.
127.19
+34.07%
BFRI Biofrontera Inc.
1.1300
+0.89%
EOLS Evolus, Inc.
9.80
-2.00%